Your browser doesn't support javascript.
loading
Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort.
Nurisyah, Sitti; Iyori, Mitsuhiro; Hasyim, Ammar Abdurrahman; Sakamoto, Akihiko; Hashimoto, Hinata; Yamagata, Kyouhei; Yamauchi, Saya; Amru, Khaeriah; Zainal, Kartika Hardianti; Idris, Irfan; Yoshida, Shigeto; Djaharuddin, Irawaty; Syafruddin, Din; Bukhari, Agussalim; Asih, Puji Budi Setia; Yusuf, Yenni.
Affiliation
  • Nurisyah S; Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
  • Iyori M; Dr. Tadjuddin Chalid Hospital, Makassar 90241, Indonesia.
  • Hasyim AA; Research Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo, Tokyo 202-8585, Japan.
  • Sakamoto A; Laboratory of Vaccinology and Applied Immunology, Kanazawa University, Kanazawa 920-1192, Japan.
  • Hashimoto H; Laboratory of Vaccinology and Applied Immunology, Kanazawa University, Kanazawa 920-1192, Japan.
  • Yamagata K; Laboratory of Vaccinology and Applied Immunology, Kanazawa University, Kanazawa 920-1192, Japan.
  • Yamauchi S; Laboratory of Vaccinology and Applied Immunology, Kanazawa University, Kanazawa 920-1192, Japan.
  • Amru K; Laboratory of Vaccinology and Applied Immunology, Kanazawa University, Kanazawa 920-1192, Japan.
  • Zainal KH; Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
  • Idris I; Dr. Tadjuddin Chalid Hospital, Makassar 90241, Indonesia.
  • Yoshida S; Laboratory of Vaccinology and Applied Immunology, Kanazawa University, Kanazawa 920-1192, Japan.
  • Djaharuddin I; Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
  • Syafruddin D; Hasanuddin University Medical Research Centre, Makassar 90245, Indonesia.
  • Bukhari A; Laboratory of Vaccinology and Applied Immunology, Kanazawa University, Kanazawa 920-1192, Japan.
  • Asih PBS; Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
  • Yusuf Y; Dr. Wahidin Soedirohusodo Hospital, Makassar 90425, Indonesia.
Antibodies (Basel) ; 12(3)2023 Sep 21.
Article de En | MEDLINE | ID: mdl-37753974
ABSTRACT

BACKGROUND:

To fight the COVID-19 pandemic, immunity against SARS-CoV-2 should be achieved not only through natural infection but also by vaccination. The effect of COVID-19 vaccination on previously infected persons is debatable.

METHODS:

A prospective cohort was undergone to collect sera from unvaccinated survivors and vaccinated persons-with and without COVID-19 pre-infection. The sera were analyzed for the anti-receptor binding domain (RBD) titers by ELISA and for the capacity to neutralize the pseudovirus of the Wuhan-Hu-1 strain by luciferase assays.

RESULTS:

Neither the antibody titers nor the neutralization capacity was significantly different between the three groups. However, the correlation between the antibody titers and the percentage of viral neutralization derived from sera of unvaccinated survivors was higher than that from vaccinated persons with pre-infection and vaccinated naïve individuals (Spearman correlation coefficient (r) = -0.8558; 95% CI, -0.9259 to -0.7288), p < 0.0001 vs. -0.7855; 95% CI, -0.8877 to -0.6096, p < 0.0001 and -0.581; 95% CI, -0.7679 to -0.3028, p = 0.0002, respectively), indicating the capacity to neutralize the virus is most superior by infection alone.

CONCLUSIONS:

Vaccines induce anti-RBD titers as high as the natural infection with lower neutralization capacity, and it does not boost immunity in pre-infected persons.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Antibodies (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Indonésie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Antibodies (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Indonésie